A Comprehensive Review of Phytochemical Approaches in Treatment of Acute Myeloid Leukemia: Associated Pathways and Molecular Mechanisms

Overview

Journal Chin Herb Med

Publisher Elsevier

Date 2025 Feb 14

PMID 39949810

Authors

Mouvanal Sajana

T S Gopenath

Basalingappa M Kanthesh

Affiliations

Soon will be listed here.

Abstract

Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow This review conducts a thorough analysis of AML, addressing its genetic modification. The examination extends to the current therapeutic approaches employed for AML, shedding light on their efficacy and the notable side effects experienced by patients undergoing these treatments, leading to a low overall survival rate. Therefore, exploring alternative treatments, such as phytochemicals, is necessary. Furthermore, the review explores the complex landscape of phytochemicals, categorizing them based on their diverse properties, which include alkaloids, phenols, terpenoids, organo-sulfur compounds, and other compounds, including quinones, and elucidating their mechanisms of action. Special emphasis is placed on their involvement in critical signaling pathways, with a particular focus on how these phytochemicals impact AML when evaluated across a spectrum of cell lines. This in-depth exploration aims to uncover potential targets within the molecular landscape of AML where phytochemicals can exert their therapeutic effects. The review investigates the potential role of plant-derived phytochemicals as adjunctive therapies for AML. This exploration encompasses the identification of specific phytochemicals that exhibit promising anti-leukemic properties and evaluates their potential in clinical settings. Beyond conventional treatments, the review explores the integration of complementary and alternative medicine as a holistic approach to managing AML. The examination encompasses the synergy between conventional therapies and alternative interventions, exploring how these combined strategies may enhance overall therapeutic outcomes and mitigate side effects. From a forward-looking perspective, the overarching goal is to contribute to the evolving landscape of AML treatment by considering innovative approaches that harness the therapeutic potential of phytochemicals, both independently and in conjunction with established medical interventions.

References

Dantas B, Faheina-Martins G, Coulidiati T, Barbosa Bomfim C, Dias C, Barbosa-Filho J . Effects of curine in HL-60 leukemic cells: cell cycle arrest and apoptosis induction. J Nat Med. 2015; 69(2):218-23. DOI: 10.1007/s11418-014-0881-5. View

Ersoz N, Adan A . Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes. Med Oncol. 2022; 39(3):35. DOI: 10.1007/s12032-021-01627-2. View

Dias M, Pinto D, Silva A . Plant Flavonoids: Chemical Characteristics and Biological Activity. Molecules. 2021; 26(17). PMC: 8434187. DOI: 10.3390/molecules26175377. View

DiNardo C, Stein E, de Botton S, Roboz G, Altman J, Mims A . Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. N Engl J Med. 2018; 378(25):2386-2398. DOI: 10.1056/NEJMoa1716984. View

Wang E, Baron J . Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop. Hematology Am Soc Hematol Educ Program. 2020; 2020(1):57-66. PMC: 7727512. DOI: 10.1182/hematology.2020000089. View

Daver N, Schlenk R, Russell N, Levis M . Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019; 33(2):299-312. PMC: 6365380. DOI: 10.1038/s41375-018-0357-9. View

Coulibaly A, Haas A, Steinmann S, Jakobs A, Schmidt T, Klempnauer K . The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression. PLoS One. 2018; 13(2):e0190934. PMC: 5796697. DOI: 10.1371/journal.pone.0190934. View

Wei A, Tiong I . Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML. Blood. 2017; 130(23):2469-2474. DOI: 10.1182/blood-2017-08-784066. View

Li Z, Suo F, Guo Y, Cheng H, Niu S, Shen D . Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation. Bioorg Chem. 2020; 97:103648. DOI: 10.1016/j.bioorg.2020.103648. View

10.

Li Z, Huang W, Tu R, Gu P, Lin C, Liou C . Sophoraflavanone G Induces Apoptosis in Human Leukemia Cells and Blocks MAPK Activation. Am J Chin Med. 2016; 44(1):165-76. DOI: 10.1142/S0192415X16500117. View

11.

Roma A, Rota S, Spagnuolo P . Diosmetin Induces Apoptosis of Acute Myeloid Leukemia Cells. Mol Pharm. 2018; 15(3):1353-1360. DOI: 10.1021/acs.molpharmaceut.7b01151. View

12.

Hasserjian R, Campigotto F, Klepeis V, Fu B, Wang S, Bueso-Ramos C . De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014; 89(11):E193-9. DOI: 10.1002/ajh.23808. View

13.

Tiong I, Wei A . New drugs creating new challenges in acute myeloid leukemia. Genes Chromosomes Cancer. 2019; 58(12):903-914. DOI: 10.1002/gcc.22750. View

14.

Carter J, Hege K, Yang J, Kalpage H, Su Y, Edwards H . Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. Signal Transduct Target Ther. 2020; 5(1):288. PMC: 7746731. DOI: 10.1038/s41392-020-00361-x. View

15.

Kim S, Lee I, Baek H, Shin I, Moon C, Bae C . Mechanism for the protective effect of diallyl disulfide against cyclophosphamide acute urotoxicity in rats. Food Chem Toxicol. 2013; 64:110-8. DOI: 10.1016/j.fct.2013.11.023. View

16.

Kopustinskiene D, Jakstas V, Savickas A, Bernatoniene J . Flavonoids as Anticancer Agents. Nutrients. 2020; 12(2). PMC: 7071196. DOI: 10.3390/nu12020457. View

17.

Chen K, Gilabert-Oriol R, Bally M, Leung A . Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia. Pharm Res. 2019; 36(9):125. PMC: 6591181. DOI: 10.1007/s11095-019-2654-z. View

18.

Yang Y, Han Z, Tian T, Liao Q, Geng J, Xiao Y . Chemical constituents from aerial parts of . Chin Herb Med. 2023; 15(1):151-154. PMC: 9975620. DOI: 10.1016/j.chmed.2021.12.007. View

19.

Alhuthali H, Bradshaw T, Lim K, Kam T, Seedhouse C . The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun. BMC Cancer. 2020; 20(1):629. PMC: 7341637. DOI: 10.1186/s12885-020-07119-2. View

20.

Zhou C, Martinez E, Marcantonio D, Solanki-Patel N, Aghayev T, Peri S . JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia. Leukemia. 2016; 31(5):1196-1205. PMC: 5473421. DOI: 10.1038/leu.2016.329. View